Halt the ABOMINATION of child sacrifice for big pharma blood money and protection from liability
Halt the ABOMINATION of child sacrifice for big pharma blood money and protection from liability
The CDC’s Advisory Committee has the chance to prevent the ABOMINATION of injecting babies and tots (6 months to < 5 year olds) with the experimental C19 injections.
There has never been a C19 pandemic amongst tots, no emergency, nada. There is hence no medical, scientific, legal, moral, ethical or philosophical bases for declaring emergency measures or an emergency use authorization of mRNA injections.
Maybe the ACIP can consider the actions of other countrie, including those that have ended vaccine mandates because the “vaccines” have simply failed:
From here:
“June 24th, 2022 12:33 pm| by The Copenhagen Post
The COVID-19 vaccine will no longer be recommended for children, according to Søren Brostrøm, the head of the Sundhedsstyrelsen health authority.”
And here:
Sweden decides against recommending COVID vaccines for kids aged 5-11 | Reuters
““Sweden has decided against recommending COVID vaccines for kids aged 5-11, the Health Agency said on Thursday, arguing that the benefits did not outweigh the risks.
"With the knowledge we have today, with a low risk for serious disease for kids, we don't see any clear benefit with vaccinating them," Health Agency official Britta Bjorkholm told a news conference.”
Even the pro-vaccination UK government does not recommend injecting tots.
Coronavirus (COVID-19) vaccine for children aged 5 to 15 - NHS (www.nhs.uk)
h/t to Steve Kirsch whose SubStack email alerted me to the meeting here:
From here:
ACIP Meeting Agenda October 19-20 2022 (cdc.gov)
In two days, the CDC’s highly qualified and experienced ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) will discuss whether or not to recommend amendments to the “vaccination” schedules for children and adults.
Thursday’s agenda has this item:
9:00 Combined Immunization Schedule
2023 child and adolescent schedule revisions – Presented by Dr. Patricia Wodi (CDC/NCIRD)
2022 adult schedule revisions - Presented by Dr. Neil Murthy (CDC/NCIRD)
The risk to babies and tots far outweighs any possible benefit. This should be a no-brainer. The submission only causes great harms by providing the likes of Pfizer, Moderna and Novavax with extortionate profits from blood money.
Let’s dive in.
The Pfizer case previously put forward by the CDC is here:
GRADE: Pfizer-BioNTech COVID-19 Vaccine for Children Aged 6 Months–4 Years | CDC
I take issue with the use of the 95% confidence interval as a general premise for estimating risk. The confidence interval is intended to capture 95% of outcomes distributed around the mean of the general population. This means 47.5% either side of the mean to span outcomes with a 2.5% probability of occurrence to 97.5% (97.5% - 2.5% = 95%). My issue is that those at risk lie only to the extreme left of the distribution curve, BELOW 2.5% of outcomes. The characteristics of those that reside in that left hand 2.5% are of the most interest and are at most risk. The treatment of this 2.5% at risk group largely comports with the principles of the Great Barrington Declaration to treat the most vulnerable. It occurs to me that the 2.5% most at risk from C19 is entirely different from the 2.5% at risk in the injected group. There is also the issue of recoveries – full or partial – from C19 compared to the suffering in the injected group in general. The absolute numbers in each needs to be analysed, as does the temporal progression within the C19 infected group and the C19 injected group. I would appreciate any help from any actuaries, CFA’s, bankers, risk and investment managers of the applicability of VaR techniques to this “Lives at Risk” concept that could also be applied to each of the leading causes of death separately.
Around 6 tots per million might die each year with C19 present; a case for injections must assume that historic tot mortality numbers are repeated. There is a strong probability that the required two doses of C19 injections for a “Primary Series”, even with a lower dosage for tots, will cause around 1,884 deaths per million tots (942 deaths per million doses).
Killing 314 tots per million every year, in order to save one tot is not good outcome.
Not only has there never been a pandemic or emergency amongst tots, this increase in likely deaths per million points clearly to motivations that are not related to the health of tots at all.
Other than a return to the worship of Moloch, manufacturers of the toxic MRNA injections, Pfizer, Moderna and Novavax plus a few others, are motivated by the desperate need to escape from any potential liability to harms caused by their toxins. Only fraud and corruption (and they stink of it) can break their liability shield.
Once companies like Pfizer and Moderna gain access to the Child Vaccination Schedule they will by extension, because of the arcane provisions in other legislation around liability for harms caused by vaccinations, be exempt from prosecution for all harms caused by their failed and toxic injections for the entire population – because, in federal law, whatever is deemed safe for children is automatically deemed safe for adults.
In other words, an approval of injections for 17 million tots, confers immunity from prosecution of harms resulting from the toxic injections by all Americans (265 million Americans have received at least one dose).
Of note, there has never been a vaccination under Emergency Use Authorization included on a Child Vaccination Schedule. A recommendation to inject tots on this basis would be the first in history.
The injections are not and never have been “vaccines”. They were described by Pfizer and Moderna on relevant SEC filings as gene modification therapies. Such therapies have a completely different regulatory burden. The WHO changed the definition of “vaccine” to redefine these gene therapies AFTER THE EVENT to suit the mRNA manufacturers. These “vaccines” do not prevent infection or transmission (in fact they increase rates of infection and susceptibility to a host of other diseases and conditions) and are being increasingly proven to be ineffective at preventing hospitalization and death.
The C19 risks for tots
The CDC provides data by age in years here:
The data table shows Total Deaths and C19 deaths for the 33 months from 1 January 2020 to 8 October 2022 – intra period data is not available. It is likely that the deaths were more concentrated at the onset of the pandemic, rather than during the last eleven-month period of the milder Omicron variant. This probably means that the annual deaths per million is closer to 3 deaths per million for tots than the historic annualized rate of 6 per million.
Over the full period, there have been 288 deaths for tots who were between 6 months and 4 years old, inclusive. This works out at an annualized rate of 104 deaths. These age buckets are completely arbitrary, each child is different around the inside and outside of age buckets. (Out of interest, the number of deaths of 3 and 4 year olds was less than half that of each of 6-11 month olds and 1 year olds).
There are 19.3 million tots 4 and under. If we assume an even population distribution, we can reduce this by an eighth (8 x six month periods = 4 years) to remove babies under 6 months and get to the number of tots over 6 months up to and including 4 years. Call it 17 million for ease. The CDC uses different age buckets for different data sets, making direct comparison difficult.
Annualizing the 288 deaths for the full 33 month period, we get 104 deaths out of 17 million = a population mortality rate of 0.0006% or 6 per million per annum.
Data for adults indicates that around 95% of those that succumb to C19 have 2-6 co-morbidities (and had already lived 1-2 years longer than population life expectancy). There is no easily accessible data to see if this percentage also applies to 6 months to 4 year olds, but there is no data to refute this statistic either. If the 95% number is borne out, the chances of a healthy tot succumbing to C19 is effectively ZERO.
Using Worldometer data, the US population case rate over the duration of the pandemic is around 30%; the infection rate is probably around three times that at 90%. The annualized case rate is around 10% for the general population, of that 10% annualized case rate there is a a 97% recovery rate (after a few weeks), a 1% case mortality rate and a 2% remaining active case rate
Recent carefully researched estimates of infection fatality rates (IFR) indicate that “*The median IFR was 0.0003% at 0-19 years, 0.003% at 20-29 years, 0.011% at 30-39 years, 0.035% at 40-49 years, 0.129% at 50-59 years, and 0.501% at 60-69 years.”
These are infection rates, not case rates. There is a discrepancy between the 0.0003% (3 in a million) – is this unannualized, so around one third that number annualized? - for the more global (pre-print) study on medRxiv amongst 0-19 year olds and the annualized 0.0006% (6 in a million) from CDC data for C19 deaths amongst 6 months to 4 year olds. It might be argued that this is a distinction without a difference.
The lives of each of these 3 or 6 in a million tots is precious; but there is not and there has never been an “emergency” C19 pandemic amongst tots.
The risks of C-19 injections for tots
Let’s start with the adult clinical trials. In the six month Pfizer (and Moderna) clinical trials for the healthier adults that Pfizer selected for the, two dose, injected sample group of around 21,900, there were 20 all cause mortality deaths (v 14 in the placebo). This represents a mortality rate of 913 per million (0.0913%).
We can compare that 913 per million number for adults in the six month clinical trial with 6 deaths per million per annum of C19 deaths for tots over the course of the pandemic. Maybe we should double the clinical trial data to annualize it.
The injection group all-cause mortality rate in the six month Pfizer (healthy adult) clinical trial is over 150 times higher than the annualized mortality rate from C19 amongst tots over the course of the pandemic. Annualize the clinical trial mortality rate as you wish!
Adverse events in that clinical trial were 24% (6% in the placebo) indicating around 240,000 adverse events per million. Staggering. Whether the milder adverse events developed into severe, then serious (life threatening) events then deaths beyond the date of the clinical trial is not known. We know that the recovery rate for C19 over the course of the pandemic is 97%, close to 100% once undetected infections are taken into account.
There have been 6.6 million global deaths reported with C19 present; which is less than 0.1% of the 8 billion global population for the 33 months of the pandemic, equal to 0.03% per annum.
Annoyingly. there is no data presented for recoveries in the clinical trial. Infections generally last just 15 days, so 15/180 x infections likely remained at the end of the clinical trail, reducing the number of cases in the placebo group from 850 to just 70. The injected group had 77 cases that likely reduced to just 6 on the same basis. Similarly, there is no global data available on the demographic characteristics of those that succumbed.
The failure to report recoveries in placebo and treated groups is a major flaw in quality of ALL clinical studies.
There is no data on the demographic characteristics of the deaths in the clinical trials. One thing we know for sure is that NO TOTS were included in the trials and that the annualized mortality rate of 6 per million for tots aged between 6 months to four year olds in the US is almost 200 TIMES LESS than the annualized US mortality rate of 1,177 annualized deaths per million from the pandemic (3,255 US deaths per million for the full 33 months) reported on the Worldometer web site.
I have referenced the analysis linked below by the Canadian Critical Care Alliance CCCA) in many articles, check out pages 11 and 12 for adverse event and mortality data compared to the claimed reduction in C19 cases.
It is worth repeating that the reduction in infections was never an end point of the clinical trial. The only end point was a reduction in symptoms and severity of disease. Page 11 indicates this actually increased and should have failed the clinical trials right there.
The COVID-19 Inoculations - More Harm Than Good FINAL Video & Print - MoreHarm.pdf | DocDroid
The FDA has used “immuno-bridging” to perform an application of characteristics of older age cohorts to younger cohorts. Will they re-examine the Pfizer (and Moderna) clinical trial data for adverse events and deaths PLUS the estimates of deaths and harms from VAERS and EUDRA, in the context of the lack of any evidence of a pandemic amongst tots? Surely the philosophy cannot remain “we need to inject a solution that contains PEG coated, lipid nano particles that instruct the body to produce spike proteins – each of which we know to be toxic – to see how many survive”?
On top of which the FDA has not enforced SUPAC production protocols (or provided reports on compliance with 21 US Codes S531 and S360d) to shut down deficient manufacturing plants (Moderna has been busted, see previous article) in order to ensure quality of “scale up of production” (the vials are NOT the same as those in the clinical trial!!!) nor will the FDA test/sample to see if the super-frozen vials are properly dethawed before their injection by non-pharma employees - a process which is an essential and integral part of the production process!
We know that the claimed reduction in cases was NOT one of the three end-points in the trial design and we know that cases have exploded since the introduction of injections – further proving the irrelevance of this variable in the clinical trial.
The clinical trials in 2020 and the introduction of injections both in the US and globally in 2021 predictably FORCED new variants – just as the new bivalent injections are forcing the emergence of the BQ1 and BQ1.1 Omicron sub-variants of BA5 now (6% prevalence so far here):
What To Know About The New COVID Subvariants And How To Best Protect Yourself (msn.com)
To stress the point, vaccinating into a pandemic simply FORCES variants to escape that may or may not be more deadly and infectious than ancestral strains.
For further context, here is some data on flu and pneumonia deaths over 2008 to 2015 by age cohort showing 21-82 flu deaths and around 400-530 pneumonia deaths per year for tots. Maybe vaccines and treatments have reduced these numbers and flu vaccine effectiveness for tots is high. (It is required that more than 50% efficacy is required for Emergency Use Authorization of an experimental gene modification therapy - the C19 injections are NOT vaccines).
Influenza and pneumonia deaths by influenza season and age: United States, 2008–2015 (cdc.gov)
Back to harms.
Let’s revisit US VAERS data, adjusted for the Under-Reporting Factor (URF) of 40. Remember the URF of 40 is two and a half times higher than the URF of more than 100 estimated in the Lazarus Report of 2011.
From here:
VAERS Summary for COVID-19 Vaccines through 10/7/2022 – VAERS Analysis
There have been 14,790 US deaths and 880,882 US adverse events reported to VAERS for C19 injections. Scaling these by a URF of 40, results in figures adjusted for under-reporting of 591,600 deaths and 35.2 million injuries (multiple injuries per person). I have not done any age stratified, dose dependent, C19 infection (past within, say, 60 days of a positive test or subsequent C19 infections – compared to injection status on VAERS data) or recidivism analysis of VAERS data for repeat injuries to the same individual, so these are generalizations. Surgeon General Ladapo of Florida has completed significant work that highlights age stratified data and overall mortality data that better informs debate than such generalizations, but I can find little to no data compiled on a similar basis across the US, rather than in that one enlightened State.
Combining the VAERS data with data from here on numbers of injections, we can estimate the mortality and injury rate per million people and per million doses.
CDC COVID Data Tracker: Vaccinations in the US
Number of doses administered = 628 million with 265 million Americans having taken at least one dose. 226 million have completed the “Primary Series”, 111 million the first booster and 26 million of those >=50 years old have taken a second booster. (The field has *** notation with no explanation on the web page).
Given 591,600 VAERS adjusted deaths, that equates to 942 deaths per million doses and 2,232 per million of the population injected with at least one dose. A “Primary Series” is two doses, so 1,884 deaths per Primary Series. This is the number that should be used for the likely death toll for tots.
A little under a quarter of Americans double dosed (56 million) will have suffered an adverse reaction (multiple per person).
The 942 deaths per million doses, needs to be multiplied by 2 to get to “Completed Primary Series” status. That 1,884 deaths per million doses can be used to estimated the rate of mortality in tots.
Out of interest, here are some details on these two CDC presenters to ACIP and the members of ACIP advisory committee. Not that the recommendations of the committee carry any weight with CDC Director Walensky, who can (and has) ignored the committee and its recommendations.
http://champsonline.org/assets/files/2022CHAMPS-IZWebcastHandouts.pdf
“Dr. Wodi holds a Doctor of Medicine degree from the College of Medicine, University of Port-Harcourt in Nigeria, and is board certified in general pediatrics and pediatric infectious diseases.”
“At the CDC, she is the co-lead for the Advisory Committee on Immunization Practice Combined Immunization Schedule Work Group, an editor for the Epidemiology and Prevention of Vaccine-Preventable Disease textbook (Pink Book), provides immunization educational resources and training to healthcare personnel, and has worked on several research studies in vaccine safety.”
Neil Murthy, MD, MPH, MSJ Medical Epidemiologist; Lieutenant Commander, U.S. Public Health Service at Centers for Disease Control and Prevention, Atlanta, Georgia, United States
He was deployed to the CDC COVID-19 Response Vaccine Task Force and took up his current position as Medical Epidemiologist in June 2021, having joined the CDC 6 years ago.
Dr Murthy has a full career profile on LinkedIn here:
https://www.linkedin.com/in/neilmurthy
Members of ACIP are here:
https://www.cdc.gov/vaccines/acip/members/bios.html
Lynn Bahta, RN, MPH, CPH
Beth P. Bell, MD, MPH
Oliver Brooks, MD, FAAP
Wilbur H. Chen, MD, MS, FIDSA, FACP
Sybil Cineas, MD, FAAP, FACP
Matthew F. Daley, MD
Camille N. Kotton, MD, FIDSA, FAST
James Loehr, MD, FAAFP
Grace M. Lee, MD, MPH
Sarah S. Long, MD
Veronica V. McNally, J.D.
Katherine A. Poehling, MD, MPH
Pablo J. Sanchez, M.D.
Nirav D. Shah, MD, JD
Helen Keipp Talbot, MD, MPH
Perhaps Veronica McNally of the Franny Strong Foundation is best placed to understand the consequences of the dangers of “vaccines”.
I think here: "1,884 deaths per million tots (942 deaths per dose)" you meant 942 deaths per million doses. Otherwise spot on, based on a quick read!
Once even 1 red flag from a single death, or a potentially life changing injury has been caused by whatever jab.
Surely the regulatory bodies of any sensible government would immediately stop any further folk being put at risk.
Then the fine tooth comb & glaring spotlight of scientific scrutiny examine & scrutinise the jab data all over again.
The waving through of life changing, up to & including fatal outcomes from these jabs under emergency use regulation. Was at best ill thought out & ill advised.
I might be missing something for sure. But how on earth can the USA continue down the jab babies path. When more than 1 country has banned the same jabs for babies & children?
All involved should be immediately rounded up & charged to courts of law.
Minimum charge would be Malfeasance. Murder 1 also applicable.
If the scientific model has been abandoned, then get the legal guns blazing & put an end to the insanity possessing too many govtards worldwide.